Product Images Topiramate

This is a graph showing the cumulative rates for time to the first seizure in two groups of participants who were given two different doses of Topiramate (50 mg/day and 400 mg/day) for treatment. The graph shows that the group taking 400 mg/day had a significantly lower rate of first seizure than the group taking 50 mg/day (p=0.0002). The graph also shows time in days along the X-axis and cumulative rates along the Y-axis.*

The text provides information on the change from baseline to double-blind phase in the average monthly migraine period rate for different doses of topiramate compared to a placebo. The results of the study are represented in a tabular form, including the number of participants at each dose level and the statistical significance. Therefore, the text describes the findings of a clinical trial on the efficacy of topiramate for the prevention of migraines.*

This seems to be a medication description of Topiramate 25mg Tab, which is a white round tablet with the imprint ZD;16. It is a generic version of Topamax 25mg Tab manufactured by Cadila Healthcare Limited. The medication should be stored at room temperature of 20°-25°C (68™-77°F) and kept tightly closed. The rest of the text seems to be identifying information such as batch number, expiration date, and NDC number.*